89. Collection of medical, cost, financial, and accounting data on services related to eye diseases, endocrine system disorders, and highly specialized services

The President of the Agency for Health Technology Assessment and Tariff System hereby notifies healthcare providers that have entered into a contract with the National Health Fund for the provision of healthcare services in the form of inpatient treatment and, during the period from January 1, 2024, to January 31, 2025, provided healthcare services related to eye diseases, endocrine system diseases, and highly specialized services under the following product codes:

5.51.01.0002053_Moderate procedures on the cornea and sclera*

5.51.01.0002023_Moderate procedures on the lens*

5.51.01.0002025_Secondary lens implantation*

5.51.01.0002074_minor procedures for glaucoma and the choroid*

5.51.01.0002081_major procedures on the retina*

5.51.01.0002004_corneal transplant – Category I*

5.51.01.0018090_procedures involving phacoemulsification <18 years of age *

5.51.01.0018091_procedures involving vitrectomy <18 years of age *

5.51.01.0002011_Comprehensive cataract and glaucoma procedures*

5.51.01.0002006_Corneal transplant – Category III*

5.51.01.0018092_Moderate procedures on the orbit and lacrimal apparatus < 18 years of age *

5.51.01.0018096_minor intraocular procedures < 18 years of age*

5.51.01.0002005_corneal transplant – category II*

5.51.01.0002031_major reconstructive procedures on the protective structures of the eye*

5.51.01.0018095_major glaucoma and choroidal surgeries <18 years of age*

5.51.01.0018094_major corneal and scleral surgeries <18 years of age*

5.51.01.0002083_moderate vitreoretinal procedures*

5.51.01.0018093_procedures involving extraocular muscles <18 years of age*

5.51.01.0002042_major procedures on the orbit and lacrimal apparatus*

5.51.01.0002007_corneal prosthetics*

5.51.01.0002003_vertoporfin treatment using photodynamic therapy*

5.51.01.0010006_endocrinological emergencies

5.51.01.0010054_Autoimmune multisystem disorders

5.51.01.0018065_Diagnostic procedures of the thyroid, parathyroid, and adrenal glands < 18 years of age*

5.51.01.0018089_procedures involving the thyroid and parathyroid glands < 18 years of age *

5.51.01.0010005_diagnostic procedures of the thyroid, parathyroid, and adrenal glands *

5.54.01.0000057_Option 1 – Transcatheter (TF, TS) aortic valve implantation

5.54.01.0000069_Option 1 – Transcatheter non-surgical mitral valve repair

5.54.01.0000092_option 2 – transcatheter repair of tricuspid valve regurgitation using the edge-to-edge method with a clip.

The tentative schedule for collecting data provided by healthcare providers is as follows:

• by 26 March 2026 – publication of the announcement and distribution of WuD forms to the sample
• by 9 April 2026 – submission of declarations – link
• by 16 April 2026 – submission of Applications (WuD declarations)
• 29 April 2026 – training
• by 29 May2026 – submission of DSz

Please submit your data using the Cost Data application—click here.

Publication on the Public Information Bulletin >>